Precision medicine tailors treatment based on the genetic profile of an individual's cancer. By understanding the genetic mutations driving a tumor, doctors can prescribe treatments that specifically target those alterations. This personalized approach has led to the development of drugs like Olaparib for BRCA-mutated ovarian cancer, offering more effective and less toxic treatment options.
